4//SEC Filing
Laube Lynne Marie 4
Accession 0001666071-22-000140
CIK 0001666071other
Filed
Nov 7, 7:00 PM ET
Accepted
Nov 8, 4:49 PM ET
Size
8.4 KB
Accession
0001666071-22-000140
Insider Transaction Report
Form 4
Cardlytics, Inc.CDLX
Laube Lynne Marie
DirectorChief Operating Officer
Transactions
- Sale
Common Stock
2022-11-08$3.98/sh−352$1,403→ 313,551 total - Sale
Common Stock
2022-11-07$4.32/sh−6,430$27,778→ 313,903 total
Holdings
- 14,565(indirect: See Footnote)
Common Stock
- 14,565(indirect: See Footnote)
Common Stock
Footnotes (4)
- [F1]Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on October 6, 2022.
- [F2]The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $4.16 to $4.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Keegan George Allbright.
- [F4]The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Hayley Marie Allbright.
Documents
Issuer
Cardlytics, Inc.
CIK 0001666071
Entity typeother
Related Parties
1- filerCIK 0001730687
Filing Metadata
- Form type
- 4
- Filed
- Nov 7, 7:00 PM ET
- Accepted
- Nov 8, 4:49 PM ET
- Size
- 8.4 KB